111 related articles for article (PubMed ID: 29998573)
1. Evaluation of compounded aqueous milbemycin oxime: issues with formulation potency and reproducibility.
Cochrane ZN; Berger DJ; Viall AK; Schrunk D; Hans Coetzee JF
J Small Anim Pract; 2019 Jan; 60(1):27-31. PubMed ID: 29998573
[TBL] [Abstract][Full Text] [Related]
2. Long-term Stability of a Compounded Suspension of Torsemide (5 mg/mL) for Oral Administration.
Adin D; Johnson PR; Kim CH; Nguyenba T; Rosen S
J Vet Intern Med; 2017 Nov; 31(6):1822-1826. PubMed ID: 28913839
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy.
Karara AH; Hines R; Demir Z; Nnorom B; Horsey R; Twigg G
Int J Pharm Compd; 2016; 20(6):461-467. PubMed ID: 28339384
[TBL] [Abstract][Full Text] [Related]
4. Accuracy and precision of compounded ciclosporin capsules and solution.
Umstead ME; Boothe DM; Cruz-Espindola C; Macdonald JM; Kennis R; Angarano D
Vet Dermatol; 2012 Oct; 23(5):431-e82. PubMed ID: 22970897
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oral afoxolaner plus milbemycin oxime chewables against induced gastrointestinal nematode infections in dogs.
Fankhauser R; Hamel D; Dorr P; Reinemeyer CR; Crafford D; Bowman DD; Ulrich M; Yoon S; Larsen DL
Vet Parasitol; 2016 Jul; 225():117-22. PubMed ID: 27369586
[TBL] [Abstract][Full Text] [Related]
6. Drug content on receipt and over time for compounded formulations of famciclovir.
Johnson LR; Weaver PG; Forsythe LE; Thomasy SM; Knych HK
J Feline Med Surg; 2021 Jun; 23(6):519-525. PubMed ID: 33019848
[TBL] [Abstract][Full Text] [Related]
7. Safety evaluation of orally administered afoxolaner and milbemycin oxime in eight-week-old dogs.
Drag M; Saik J; Harriman J; Letendre L; Yoon S; Larsen D
J Vet Pharmacol Ther; 2017 Oct; 40(5):447-453. PubMed ID: 27891622
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of afoxolaner plus milbemycin oxime chewable tablets against naturally acquired intestinal nematodes in dogs.
Rehbein S; Dorr P; Bowman DD; Crafford D; Kusi I; Postoli R; Yoon S; Chester ST; Dollhofer D; Visser M; Larsen DL
Vet Parasitol; 2016 Feb; 217():29-35. PubMed ID: 26827857
[TBL] [Abstract][Full Text] [Related]
9. The intravenous and oral pharmacokinetics of afoxolaner and milbemycin oxime when used as a combination chewable parasiticide for dogs.
Letendre L; Harriman J; Drag M; Mullins A; Malinski T; Rehbein S
J Vet Pharmacol Ther; 2017 Jan; 40(1):35-43. PubMed ID: 27604405
[TBL] [Abstract][Full Text] [Related]
10. Potency and stability of compounded formulations of chlorambucil, melphalan and cyclophosphamide.
Burton JH; Knych HK; Stanley SD; Rebhun RB
Vet Comp Oncol; 2017 Dec; 15(4):1558-1563. PubMed ID: 28120478
[TBL] [Abstract][Full Text] [Related]
11. Stability and consistency of compounded oral liquid levothyroxine formulations.
Meyer LM; Stephens K; Carter CA; Pickard W; Johnson PR; Eagerton DH
J Am Pharm Assoc (2003); 2020; 60(6):e168-e172. PubMed ID: 32591200
[TBL] [Abstract][Full Text] [Related]
12. Compounding for animal patients: contemporary issues.
Lust E
J Am Pharm Assoc (2003); 2004; 44(3):375-84; quiz 384-6. PubMed ID: 15191248
[TBL] [Abstract][Full Text] [Related]
13. Variable accuracy, precision, and consistency of compounded famciclovir formulated for management of feline herpesvirus-1 in cats.
O'Leary LM; Allbaugh RA; Schrunk DE; Olsen TE; Sebbag L
Vet Ophthalmol; 2021 Nov; 24(6):627-638. PubMed ID: 34117694
[TBL] [Abstract][Full Text] [Related]
14. Quality assessment of fluconazole capsules and oral suspensions compounded by pharmacies located in the United States.
Laporte CM; Cruz-Espindola C; Thungrat K; Schick AE; Lewis TP; Boothe DM
Am J Vet Res; 2017 Apr; 78(4):421-432. PubMed ID: 28346002
[TBL] [Abstract][Full Text] [Related]
15. Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies.
Buurma H; de Smet PA; van den Hoff OP; Sysling H; Storimans M; Egberts AC
Pharm World Sci; 2003 Dec; 25(6):280-7. PubMed ID: 14689817
[TBL] [Abstract][Full Text] [Related]
16. Effects of compounding and storage conditions on stability of pergolide mesylate.
Davis JL; Kirk LM; Davidson GS; Papich MG
J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of testosterone concentrations in compounded testosterone products.
Grober ED; Garbens A; Božović A; Kulasingam V; Fanipour M; Diamandis EP
J Sex Med; 2015 Jun; 12(6):1381-8. PubMed ID: 25963000
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy of monthly oral administration of afoxolaner plus milbemycin oxime (NexGard Spectra(®), Merial) in the prevention of adult Spirocerca lupi establishment in experimentally infected dogs.
Beugnet F; Crafford D; de Vos C; Kok D; Larsen D; Fourie J
Vet Parasitol; 2016 Aug; 226():150-61. PubMed ID: 27514901
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of drug content (potency) for compounded and FDA-approved formulations of doxycycline on receipt and after 21 days of storage.
KuKanich K; KuKanich B; Slead T; Warner M
J Am Vet Med Assoc; 2017 Oct; 251(7):835-842. PubMed ID: 28967825
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of afoxolaner plus milbemycin oxime chewable tablets (NexGard Spectra
Tielemans E; Lebon W; Dumont P; Taweethavonsawat P; Larsen D; Rehbein S
Vet Parasitol; 2017 Apr; 238():87-89. PubMed ID: 28408213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
